Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Humanwell Healthcare (Group) Co's quarterly Total Liabilities
declined
from Sep. 2025 (¥14,923.42 Mil) to Dec. 2025 (¥14,739.03 Mil) but then
increased
from Dec. 2025 (¥14,739.03 Mil) to Mar. 2026 (¥14,925.87 Mil).
Humanwell Healthcare (Group) Co's annual Total Liabilities
declined
from Dec. 2023 (¥16,105.69 Mil) to Dec. 2024 (¥15,815.27 Mil) and
declined
from Dec. 2024 (¥15,815.27 Mil) to Dec. 2025 (¥14,739.03 Mil).
Humanwell Healthcare (Group) Co Total Liabilities Related Terms
Humanwell Healthcare (Group) Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humanwell Healthcare (Group) Co Total Liabilities Chart
Humanwell Healthcare (Group) Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of ¥14,926 Mil mean?
Humanwell Healthcare (Group) Co (SHSE:600079) has a Total Liabilities of ¥14,926 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Humanwell Healthcare (Group) Co and its competitors.
Is Humanwell Healthcare (Group) Co's Total Liabilities too high?
Humanwell Healthcare (Group) Co's current Total Liabilities is ¥14,926 Mil. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Total Liabilities compare to ZTS and UTHR?
Humanwell Healthcare (Group) Co's Total Liabilities of ¥14,926 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Humanwell Healthcare (Group) Co and its competitors. Humanwell Healthcare (Group) Co's current Total Liabilities is ¥14,926 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.64, compared to a current price of ¥17.59 — trading 18.7% below its estimated fair value. The current Total Liabilities is ¥14,926 Mil. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Total Liabilities is ¥14,926 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued.
The current stock price of ¥17.59 is trading 18.7% below its estimated GF Value™ of ¥21.64.
GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600079:
Total Liabilities: ¥14,926 Mil
GF Value™: ¥21.64 vs. price of ¥17.59 (18.7% below fair value)
No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humanwell Healthcare (Group) Co Business Description
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score
Get the complete analysis for SHSE:600079
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600079 has been successfully added to your 
